Actinium Pharmaceuticals, Inc. Share Price
Stocks
ATNM
US00507W2061
Biotechnology & Medical Research
|
Market Closed -
NYSE
01:30:00 30/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.140 USD | -3.39% |
|
-2.56% | -16.18% |
| 15/08 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 15/08 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
| Market Cap | 3.58Cr 3.16Cr 2.99Cr 2.71Cr 5.09Cr 343.94Cr 5.14Cr 36Cr 14Cr 175.63Cr 13Cr 13Cr 565.19Cr | P/E 2026 * |
6.45x | P/E 2027 * | -1.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.58Cr 3.16Cr 2.99Cr 2.71Cr 5.09Cr 343.94Cr 5.14Cr 36Cr 14Cr 175.63Cr 13Cr 13Cr 565.19Cr | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | - |
| Free-Float |
90.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ATNM | Delayed | |
Tradegate
| 7AY1 | Real-time | |
|
CBOE
| ATNM | Real-time | |
|
Deutsche Boerse AG
| 7AY1 | Delayed | |
|
Börse Stuttgart
| 7AY1 | Delayed | |
|
Boerse Muenchen
| 7AY1 | Real-time |
| 1 day | -3.39% | ||
| 1 week | -2.56% | ||
| Current month | +11.76% | ||
| 1 month | +12.87% | ||
| 3 months | +15.15% | ||
| 6 months | +10.68% | ||
| Current year | -16.18% |
| 1 week | 1.14 |  | 1.25 |
| 1 month | 1 | | 1.42 |
| Current year | 0.74 | | 1.53 |
| 1 year | 0.74 | | 1.74 |
| 3 years | 0.74 | | 10.24 |
| 5 years | 0.74 | | 15.12 |
| 10 years | 0.74 | | 51.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 62 | 09/06/2017 |
Steffen Heeger
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2026 |
Adeela Kamal
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Nicholson
BRD | Director/Board Member | 71 | 01/01/2008 |
Sandesh Seth
CHM | Chairman | 62 | 01/10/2013 |
| Director/Board Member | 68 | 08/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Other | Chief Technology Officer | 3,33,648 | 1.0634% | ||
| 03/09/26 | Other | Chief Technology Officer | 4,03,868 | 1.2872% | ||
| 02/09/26 | Free | Director | 1,57,000 | 0.5004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.39% | -2.56% | -29.63% | -80.74% | 3.58Cr | |
| -0.70% | -4.28% | +52.62% | +86.42% | 7.15TCr | |
| +1.01% | +2.54% | +38.85% | +83.51% | 6.01TCr | |
| +4.77% | +6.16% | +36.77% | +26.10% | 2.8TCr | |
| -1.73% | -4.30% | -18.37% | +357.94% | 2.53TCr | |
| -0.51% | -2.28% | +0.48% | -9.27% | 2.48TCr | |
| +1.17% | +2.18% | +21.50% | -4.17% | 2.1TCr | |
| +3.46% | +3.02% | +158.90% | +337.81% | 1.55TCr | |
| +0.48% | +0.86% | +44.56% | +168.42% | 1.45TCr | |
| +2.96% | +0.83% | -5.25% | +519.59% | 1.44TCr | |
| Average | +0.79% | -0.88% | +30.04% | +148.56% | 2.75TCr | |
| Weighted average by Cap. | +0.80% | -1.52% | +36.96% | +130.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.75Cr 1.54Cr 1.46Cr 1.33Cr 2.48Cr 167.92Cr 2.51Cr 18Cr 6.76Cr 86Cr 6.57Cr 6.43Cr 275.95Cr | - |
| Net income | 59.12L 52.17L 49.36L 44.77L 83.93L 57Cr 84.76L 5.92Cr 2.28Cr 29Cr 2.22Cr 2.17Cr 93Cr | -3.09Cr -2.73Cr -2.58Cr -2.34Cr -4.39Cr -296.95Cr -4.44Cr -31Cr -12Cr -151.64Cr -12Cr -11Cr -487.97Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | $1.140 | -3.39% | 62,022 |
| 28/26/28 | $1.180 | -1.67% | 75,373 |
| 25/26/25 | $1.200 | +0.84% | 28,418 |
| 24/26/24 | $1.190 | +0.85% | 85,939 |
| 23/26/23 | $1.180 | +0.85% | 1,30,427 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATNM Stock
Select your edition
All financial news and data tailored to specific country editions
